Alembic Pharmaceuticals Ltd Nine Monthly Results

Gross Sales

4,902.45

4,711.65

4,246.17

3,890.05

4,112.74

Excise Duty

0

0

0

0

0

Net Sales

4,902.45

4,711.65

4,246.17

3,890.05

4,112.74

Other Operating Income

0

0

0

0

0

Other Income

42.76

24.71

1.86

22.65

6.07

Total Income

4,945.21

4,736.36

4,248.03

3,912.7

4,118.81

Total Expenditure

4,166.13

4,038.95

3,772.5

3,141.25

2,896.88

PBIDT

779.08

697.41

475.53

771.45

1,221.93

Interest

54.25

45.25

35.8

11.03

13.46

PBDT

724.83

652.16

439.73

760.42

1,208.47

Depreciation

209.59

203.19

201.31

163.69

132.25

Minority Interest Before NP

0

0

0

0

0

Tax

101.54

35.67

53.6

111.25

198.25

Deferred Tax

-11.68

-24.31

-4.57

-13.54

0.62

Reported Profit After Tax

425.38

437.61

189.39

499.02

877.35

Minority Interest After NP

-1.15

0

0

0

-23.36

Net Profit after Minority Interest

426.53

437.61

189.39

499.02

927.4

Extra-ordinary Items

10.33

0

0

0

0

Adjusted Profit After Extra-ordinary item

416.2

437.61

189.39

499.02

927.4

EPS (Unit Curr.)

21.64

22.3

9.64

25.39

48.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.89

14.8

11.19

19.83

29.71

PBDTM(%)

14.78

13.84

10.35

19.54

29.38

PATM(%)

8.67

9.28

4.46

12.82

21.33